Monogenic Diabetes: From Genetic Insights to Population-Based Precision in Care. Reflections From a Diabetes Care Editors’ Expert Forum
Open accessThe DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Abstract
Individualization of therapy based on a person’s specific type of diabetes is one key element of a “precision medicine” approach to diabetes care. However, applying such an approach remains difficult because of barriers such as disease heterogeneity, difficulties in accurately diagnosing different types of diabetes, multiple genetic influences, incomplete understanding of pathophysiology, limitations of current therapies, and environmental, social, and psychological factors. Monogenic diabetes, for which single gene mutations are causal, is the category most suited to a precision approach. The pathophysiological mechanisms of monogenic diabetes are understood better than those of any other form of diabetes. Thus, this category offers the advantage of accurate diagnosis of nonoverlapping etiological subgroups for which specific interventions can be applied. Although representing a small proportion of all diabetes cases, monogenic forms present an opportunity to demonstrate the feasibility of precision medicine strategies. In June 2019, the editors of Diabetes Care convened a panel of experts to discuss this opportunity. This article summarizes the major themes that arose at that forum. It presents an overview of the common causes of monogenic diabetes, describes some challenges in identifying and treating these disorders, and reports experience with various approaches to screening, diagnosis, and management. This article complements a larger American Diabetes Association effort supporting implementation of precision medicine for monogenic diabetes, which could serve as a platform for a broader initiative to apply more precise tactics to treating the more common forms of diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Monogenic defects that cause b -cell dysfunction, such as neonatal diabetes and MODY, are present in a small fraction of people with diabetes ( < 5%) (155).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [155]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s002 · Cited by 3,187
Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3)
Yamagata, K., Oda, N., Kaisaki, P. J., Menzel, S., Furuta, H., Vaxillaire, M., Southam, L., Cox, R. D., Lathrop, G. M., Boriraj, V. V., et al. (1996) · Nature · doi:10.1038/384455a0 · Cited by 1,614
Self-citationLifetime risk for diabetes mellitus in the United States
Narayan, K. M. V. (2003) · JAMA · doi:10.1001/jama.290.14.1884 · Cited by 1,515
Gloyn, A. L., Pearson, E. R., Antcliff, J. F., Proks, P., Bruining, G. J., Slingerland, A. S., Howard, N., Srinivasan, S., Silva, J. M. C. L., Molnes, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032922 · Cited by 1,137
Self-citationSwitching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations
Pearson, E. R., Flechtner, I., Njølstad, P. R., Malecki, M. T., Flanagan, S. E., Larkin, B., Ashcroft, F. M., Klimes, I., Codner, E., Iotova, V., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061759 · Cited by 988
Self-citationMutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1)
Yamagata, K., Furuta, H., Oda, N., Kaisaki, P. J., Menzel, S., Cox, N. J., Fajans, S. S., Signorini, S., Stoffel, M., & Bell, G. I. (1996) · Nature · doi:10.1038/384458a0 · Cited by 976
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s009 · Cited by 914
Froguel, P., Zouali, H., Vionnet, N., Velho, G., Vaxillaire, M., Sun, F., Lesage, S., Stoffel, M., Takeda, J., Passa, P., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199303113281005 · Cited by 735
Maturity-onset diabetes of the young (MODY): how many cases are we missing?
Shields, B. M., Hicks, S., Shepherd, M. H., Colclough, K., Hattersley, A. T., & Ellard, S. (2010) · Diabetologia · doi:10.1007/s00125-010-1799-4 · Cited by 725
Self-citation
Cited by
Items 101–140 of 140
A Patient-Centered Management of Patients with Diabetes Type 2: Are All Diabetic Patients the Same?
Bosnić, Z., Šojat, D., Kurevija, T., Pirić, M., Božinović, R., Miletić, M., Feldi, I., Bačun, T., Žagar, S., & Majnarić, L. T. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1003106
Thewjitcharoen, Y., Nakasatien, S., Chatchomchuan, W., Butadej, S., Krittiyawong, S., Wanothayaroj, E., & Himathongkam, T. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e14262
Sun, S., Gong, S., Ba, T., Li, M., Liu, W., zhang, R., Ma, Y., Wang, F., Cai, X., Luo, Y., et al. (2026) · Diabetes & Metabolism · doi:10.1016/j.diabet.2026.101729
ICD-11 and diabetes: opportunities for precision public health through enhanced classification
Zhou, J., Xia, P., Li, Y., & Li, N. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1944007
Chen, Z., & Pang, H. (2026) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-026-10084-z
Review: Updates of precision medicine in type 2 diabetes — R0/PR3
Xia, M., & Li, X. (2022) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2023.12.pr3
Shah, V. N., & Akturk, H. K. (2025) · American Diabetes Association eBooks · doi:10.2337/9781580408479-references
Moreno-Fernández, J., Montoro, J. I. M., Muñoz‐Rodríguez, J. R., Herranz-Antolín, S., Marco, A., Pinés, P. J., de Ancos, M. R., González, J., Maqueda, E., Sastre, J., et al. (2026) · Medicina Clínica (English Edition) · doi:10.1016/j.medcli.2026.107450
Chen, J., Zhang, X., Wu, D., 桑艳梅, & Wang, X. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1967659
Lee, Y., Tong, M., & Gloyn, A. L. (2026) · FEBS Letters · doi:10.1002/1873-3468.70436
Precision Genetics for Monogenic Diabetes
Luk, A. O. Y., & Lim, L. (2022) · Springer eBooks · doi:10.1007/978-3-030-98927-9_6
The Pathogenic Diagnosis in Pediatric Diabetology: Next Generation Sequencing and Precision Therapy
Maione, G., IAFUSCO, F., Zanfardino, A., Piscopo, A., Özen, G., Iafusco, D., & Tinto, N. (2023) · Medicina · doi:10.3390/medicina59020310
Other Disorders with Type 1 Diabetes and Atypical Phenotypes
Kong, A. P. S., Chow, E., Luk, A. O. Y., & Chan, J. C. N. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch15
Chen, Y., Yin, M., Xie, Y., Deng, C., Xie, Z., Huang, G., Luo, S., Zhou, Z., & Li, X. (2026) · Diabetes & Metabolism · doi:10.1016/j.diabet.2026.101741
Dubois‐Laforgue, D., Donadille, B., Ciangura, C., Amouyal, C., Arnoux, J., Barat, P., Baron, S., Beltrand, J., Bismuth, É., Bouché, C., et al. (2026) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-026-04272-y
The landscape of monogenic diabetes in Italy. Comparisons with other European countries
Paola, R. D., Rutigliano, I., Fini, G., Menzaghi, C., Mansueto, M. L., Piscitelli, P. A., Rampolli, F. I., Salvemini, L., Marucci, A., & Trischitta, V. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113497
The Emerging Importance of Cellular Insulin Resistance in Diabetic Kidney Disease
Coward, R. J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821618-7.00272-8
Komati, A., Mandava, K., & Anand, A. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1822644
Diabetes Mellitus: Review of the Common, Rare, and Uncommon (Conceptual and Metaphorical) Types
Pliszka, M., & Szablewski, L. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27219611
Chen, J., Zhang, X., Li, R., Ma, R., Piao, Y., Sang, Y., & Wang, X. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1991026
Precision medicine: monogenic diabetes
Rabbone, I. (2023) · The Journal of AMD · doi:10.36171/jamd23.26.2.9
Editorial: Uncommon or rare forms of diabetes: from diagnosis to management
Grancini, V., & Bolla, A. M. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1831564
Franklin, D., Mahony, J., Patel, C., & Triay, J. (2026) · Acta Diabetologica · doi:10.1007/s00592-026-02795-1
Kibirige, D., Niwaha, A. J., Katte, J.-C. N., & Lumu, W. (2026) · Diabetes Therapy · doi:10.1007/s13300-026-01881-5
Bolas, A. F., Torres, J. O., Bogalho, P., & Silva‐Nunes, J. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1859312
Uncommon or Rare Forms of Diabetes: From Diagnosis to Management
(2026) · Frontiers research topics · doi:10.3389/978-2-8325-7878-0
Lallouet, M. (2024) · theses.fr (ABES) · doi:10.70675/29788a07z7b1fz4797zadbczf9879d053583
Kettunen, J. (2021) · Helda - University of Helsinki Institutional Repository
Dario, P. (2026) · Annals of Human Genetics · doi:10.1111/ahg.70054
Yu, H., Zhang, J., Liu, F., Liu, Y., Yan, W., & Yu, Z. (2026) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70606
Huerta‐Chagoya, A., Schroeder, P. H., Mandla, R., Li, J., Morris, L., Vora, M., Alkanaq, A. N., Nagy, D., Szczerbiński, Ł., Madsen, J. G. S., et al. (2024) · Nature Genetics · doi:10.1038/s41588-024-01986-2
Thompson, A. R. (2025) · Springer Publishing Company eBooks · doi:10.1891/9780826174567.0001
Kuramoto, K., Chen, M., & He, C. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.13.751259
Skoczylas, S., Płoszaj, T., Zmysłowska-Polakowska, E., Piekarska, K., Grzybowska-Adamowicz, J., & Zmysłowska, A. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.2009572
Stankutė, I. (2022) · Lithuanian University of Health Sciences
Кураева, Т. Л., Чернуха, П. А., & Emel'yanov, A. O. (2026) · Diabetes Mellitus · doi:10.14341/dm13434
The Clinical Spectrum and Significance of ABCC8 Gene Variants in the Diagnosis of Monogenic Diabetes
Kapelan, N., Tust, P., Skoczylas, S., Płoszaj, T., Gadzalska, K., Gorządek, M., Jakiel, P., Juścińska, E., Budzyńska, E., Borowiec, M., et al. (2026) · Diabetology · doi:10.3390/diabetology7100199
Bhattacharji, A., & D'Souza, M. R. (2026) · International Journal of Drug Delivery Technology · doi:10.25258/ijddt.16.42s.96
Mykolaitytė, J. (2021) · Lithuanian University of Health Sciences
Predictive Modelling for Diabetes Risk Assessment: An Exploratory Data Analysis Approach
Gade, S., & KENE, D. P. (2026) · International Journal for Research in Applied Science and Engineering Technology · doi:10.22214/ijraset.2026.84394
Metadata
- Authors
- Riddle, M. C., Philipson, L. H., Rich, S. S., Carlsson, A., Franks, P. W., Greeley, S. A. W., Nolan, J. J., Pearson, E. R., Zeitler, P. S., & Hattersley, A. T.
- Affiliations
- Oregon Health & Science University (US)
- University of Chicago (US)
- University of Virginia (US)
- Lund University (SE)
- Harvard University (US)
- Trinity College Dublin (IE)
- University of Dundee (GB)
- Children's Hospital Colorado (US)
- University of Exeter (GB)
- Corresponding author
- Riddle, Matthew C.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2020-11-12
- Volume
- 43
- Issue
- 12
- Pages
- 3117-3128
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC8162450
- OpenAlex
- W3106034474
- Cited by
- 117
- References
- 103
- Citations by year
- 2026: 24 · 2025: 9 · 2024: 21 · 2023: 23 · 2022: 23 · 2021: 16 · 2020: 1
- FWCI
- 2.27
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Diabetes Care (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (publishedVersion, other-oa)
- Open Research Exeter (University of Exeter) (acceptedVersion)
- Figshare (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- Wellcome Trust (102820/Z/13/Z)
- National Institute for Health and Care Research (NF-SI-0611-10219)
- Novo Nordisk Fonden (NNF18OC0034050, NNF14OC0011039, NNF17OC0026828)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK104942, P30DK020595)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- monogenic diabetes, precision medicine, genetic diagnosis, disease heterogeneity, screening, diagnosis, diabetes management, pathophysiology, genetic mutations, expert consensus
- MeSH terms
- Congresses as Topic, Diabetes Mellitus, Endocrinology, Expert Testimony, Humans, Patient-Centered Care, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.